drugset / Trial / NCT00696865

AZD2624 Multiple Ascending Dose Study in Japan

NCT00696865

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blind

Summary

This multiple ascending dose study will evaluate safety and tolerability after repeated ascending doses of AZD2624

Timeline

Start
2008-05
Primary completion
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PAVINETANT Small molecule Oral

Indications

No indication recorded.